Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday

Author: Avi Kapoor | September 11, 2024 09:08am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Ascendiant Capital raised the price target for Atossa Therapeutics, Inc. (NASDAQ:ATOS) from $6.25 to $6.5. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Atossa Therapeutics shares gained 7.4% to close at $1.46 on Tuesday. See how other analysts view this stock.
  • B of A Securities cut the price target for Novartis AG (NYSE:NVS) from $135 to $130. B of A Securities analyst Graham Perry downgraded the stock from Buy to Neutral. Novartis shares fell 0.2% to close at $116.99 on Tuesday. See how other analysts view this stock.
  • Keefe, Bruyette & Woods raised Camden National Corporation (NYSE:CAC) price target from $40 to $41. Keefe, Bruyette & Woods analyst Damon Delmonte maintained a Market Perform rating. Camden National shares fell 0.3% to close at $37.78 on Tuesday. See how other analysts view this stock.
  • Piper Sandler cut Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) price target from $41 to $36. Piper Sandler analyst David Amsellem downgraded the stock from Overweight to Neutral. Supernus Pharmaceuticals shares fell 1.2% to close at $33.49 on Tuesday. See how other analysts view this stock.
  • B of A Securities raised the price target for AppLovin Corporation (NASDAQ:APP) from $100 to $120. B of A Securities analyst Omar Dessouky maintained a Buy rating. AppLovin shares fell 0.1% to close at $86.23 on Tuesday. See how other analysts view this stock.
  • Stifel boosted Krystal Biotech, Inc. (NASDAQ:KRYS) price target from $204 to $220. Stifel analyst Dae Gon Ha maintained a Buy rating. Krystal Biotech shares fell 1.4% to close at $185.00 on Tuesday. See how other analysts view this stock.
  • BMO Capital cut Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) price target from $65 to $55. BMO Capital analyst Andrew Strelzik maintained an Outperform rating. Dave & Buster’s shares fell 0.8% to close at $29.86 on Tuesday. See how other analysts view this stock.
  • Wedbush cut the price target for GameStop Corp. (NYSE:GME) from $11 to $10. Wedbush analyst Michael Pachter maintained an Underperform rating. GameStop shares fell 3.3% to close at $23.45 on Tuesday. See how other analysts view this stock.
  • Truist Securities boosted Academy Sports and Outdoors, Inc. (NASDAQ:ASO) price target from $60 to $63. Truist Securities analyst Joseph Civello maintained a Buy rating. Academy Sports shares gained 5.2% to close at $55.38 on Tuesday. See how other analysts view this stock.
  • BMO Capital cut Domino’s Pizza, Inc. (NYSE:DPZ) price target from $525 to $510. BMO Capital analyst Andrew Strelzik maintained an Outperform rating. Domino’s shares fell 0.8% to close at $416.77 on Tuesday. See how other analysts view this stock.

Considering buying DPZ stock? Here’s what analysts think:

Posted In: APP ASO ATOS CAC DPZ GME KRYS NVS PLAY SUPN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist